MJBizDaily
FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now
Featured
Latest Posts
After Trulieve, which cannabis MSO will be next to uplist?
Cannabis companies seeking to follow Trulieve Cannabis Corp.'s lead and list on mainstream stock exchanges may have a hard road ahead.
News June 17
Michigan’s top cannabis regulator elected president of CANNRA
Regulators from Virginia, Illinois, Hawaii, Connecticut, Missouri and Iowa also will serve on CANNRA’s 2026-27 board.
News June 16
Virginia adult-use cannabis sales to begin July 2027 under new deal
License caps and tax rates both set in compromise that will see sales begin July 1, 2027.
News June 16
Do cannabis products need standardized expiration dates?
For operators, the stakes go beyond compliance – botched dating can trigger recalls, drain working capital and erode brand trust.
News June 16
Canopy Growth reports big jump in medical cannabis revenue
Canopy’s medical cannabis net revenue in the fourth quarter was $25.3 million. Its international revenue was $8.6 million.
News June 15
Texas court reinstates hemp rules, enforcement still unclear
The decision does not settle the broader lawsuit, but it removes a lower-court block that paused enforcement of portions of the regulations.
News June 12
Tribal cannabis stores hit record expansion across the US
With 19 tribes owning 26 stores, Washington has the most tribally owned cannabis retail operations of any state.
News June 12
Trulieve is first US cannabis company to trade on NYSE
CEO Kim Rivers called the listing a turning point for the cannabis sector. Analysts predict the company will break even in the next year.
News June 11
Nabis CEO on the future of interstate cannabis commerce post-rescheduling
Vince Ning says the question of whether reclassifying medical marijuana opens state borders to cannabis products remains largely unsettled.
News June 11
Latest Sponsored
